<div class="const-card dosage-chart">
      <div class="card-header">
      	<h1>SSRI Herb-Drug Interactions</h1>
      </div>

<table class="const-card-block card-block table-bordered">

	<thead class="dosage-chart__head">
			<tr>
<td>Drug/Herb Class</td>
<td>Herbs</td>
<td>Interaction</td>
<td>Level Of Caution</td>
</tr>
		</thead>
<tbody>
<tr>
<td>CNS Depressants</td>
<td>Piper methysticum</td>
<td>Increased chances of developing orthostatic hypotension</td>
<td>Caution</td>
</tr>
<tr>
<td>Anti-Diabetic drugs</td>
<td>- </td>
<td>Can increase blood glucose levels</td>
<td>Caution</td>
</tr>
<tr>
<td>Other drugs affecting platelet aggregation</td>
<td>Zingiber officinale [94]<br/>Coleus forskholii [95]</td>
<td>Increased risk of bleeding</td>
<td>Caution</td>
</tr>
<tr>
<td>MAO inhibitors</td>
<td>Phellodendron amurense [75]<br/>Glycyrrhiza uralensis [75]<br/>Psoralea corylifolia [75]<br/>Glycyrrhiza glabra [75]<br/>Cyamopsis psoralioides [75]<br/>Piper negrum [75]<br/>Camellia sinensis [75]<br/>Piper methysticum [75]<br/>Alchemilla vulgaris [75]<br/>Curcuma longa [75]</td>
<td>Increased drug effects and risk of serotonin syndrome</td>
<td>Caution</td>
</tr>
<tr>
<td>Other Serotonergics</td>
<td>Hypericum perforatum [93]</td>
<td>Increased risk of serotonin syndrome</td>
<td>Contraindicated</td>
</tr>
<tr>
<td>CYP2D6 Inhibitors <br/>(Fluoxetine)</td>
<td>Berberis vulgaris [9, 10]<br/>Centella asiatica [42]<br/>Eschscholzia californica [16]<br/>Filipendula ulmaria [55, 56]<br/>Glycyrrhiza glabra [53, 66]<br/>Hydrastis Canadensis [9, 41]<br/>Melissa officinalis [51, 52]<br/>Silybum marianum [57, 58]<br/>Withania somnifera [90]</td>
<td>Increased half-life and risk of serotonin syndrome</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP2D6 Inducers <br/>(Fluoxetine)</td>
<td>-</td>
<td>Decreased drug effect</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP3A4 Inhibitors <br/>(Fluoxetine, Fluvoxamine)</td>
<td>Arctostaphylos uva-ursi [81]<br/>Astragalus membranaceus [5]<br/>Bacopa monieri [6]<br/>Berberis vulgaris [9, 10]<br/>Boswellia serrata [34, 35]<br/>Centella asiatica [42]<br/>Cinnamomum verum [21]<br/>Eschscholzia californica [16]<br/>Filipendula ulmaria [55, 56]<br/>Ginkgo biloba [38, 67]<br/>Gymnema sylvestre [43]<br/>Hydrastis Canadensis [9, 41]<br/>Hypericum perforatum [67, 76]<br/>Melissa officinalis [51, 52]<br/>Paeonia lactiflora [86]<br/>Panax ginseng [49]<br/>Passiflora incarnata [63]<br/>Rosmarinus officinalis [66]<br/>Salix alba [55]<br/>Scutellaria baicalensis [8]<br/>Scutellaria lateriflora [74]<br/>Tabebuia impetiginosa [39]<br/>Vitex agnus-castus [20]<br/>Withania somnifera [90]</td>
<td>Increased half-life and risk of serotonin syndrome</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP3A4 Inducers <br/>(Fluoxetine, Fluvoxamine)</td>
<td>Andrographis paniculata [4]<br/>Taraxacum officinale [25, 26]<br/>Leonurus cardiaca [59]</td>
<td>Decreased drug effect</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP1A2 Inhibitors <br/>(Fluvoxamine)</td>
<td>Bacopa monieri [6]<br/>Boswellia serrata [34, 35]<br/>Equisetum arvense [46, 47]<br/>Eschscholzia californica [16]<br/>Gymnema sylvestre [43]<br/>Humulus lupulus [45]<br/>Matricaria recutita [19, 24]<br/>Passiflora incarnata [62, 63]<br/>Rosmarinus officinalis [66]<br/>Scutellaria baicalensis [54]</td>
<td>Increased half-life and risk of serotonin syndrome</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP1A2 Iducers <br/>(Fluvoxamine)</td>
<td>Echinacea angustifolia [29, 30]<br/>Melissa officinalis [51, 52]</td>
<td>Decreased drug effect</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP2C19 Inhibitors <br/>(Fluvoxamine)</td>
<td>Bacopa monieri [6]<br/>Berberis vulgaris [9, 10]<br/>Eschscholzia californica [16]<br/>Vitex agnus-castus [20]</td>
<td>Increased half-life and risk of serotonin syndrome</td>
<td>Caution</td>
</tr>
<tr>
<td>CYP2C19 Inducers <br/>(Fluvoxamine)</td>
<td>- </td>
<td>Decreased drug effect</td>
<td>Caution</td>
</tr>
</tbody></table>

</div>